Phase 1B Study of PD-0332991 in Combination With T-DM1 in the Treatment of Patients With Advanced HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2017
At a glance
- Drugs Palbociclib (Primary) ; Trastuzumab emtansine
- Indications Breast cancer; Male breast cancer
- Focus Adverse reactions
- 16 Nov 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2020.
- 16 Nov 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
- 10 Jun 2017 Biomarkers information updated